Revolutionising obesity treatment with new gender-specific microbiome findings
Recent investigations to be unveiled at the European Congress on Obesity (ECO) held in Venice, Italy, from the 12th to the 15th of May, 2024, have shed light on the pivotal role that variations in gut microbiota composition play in the genesis and evolution of obesity, revealing notable distinctions between genders. This differentiation may significantly influence the metabolism of various...Read MoreHealthcare professionals struggle to tackle childhood obesity due to insufficient training
In the face of the escalating childhood obesity crisis, healthcare professionals are encountering significant hurdles, primarily due to a glaring deficiency in training and operational bandwidth. This predicament was illuminated through a study published in the British Journal of General Practice, wherein researchers from the University of Birmingham conducted thorough interviews with...Read MoreStudy reveals sweeteners do not elevate hunger while aiding in blood sugar reduction
In a groundbreaking research endeavour, the substitution of sugar with both artificial and natural sweeteners has been shown to not increase hunger levels in individuals, whilst also facilitating a reduction in blood sugar levels. This discovery comes from a rigorous double-blind randomised controlled trial, which observed that foods containing sweeteners do not lead to heightened appetite...Read MoreObesity during youth could double the risk of multiple sclerosis in later life, research suggests
Children grappling with obesity might face a significantly higher likelihood of being diagnosed with multiple sclerosis (MS) in adulthood, according to recent research findings. Multiple sclerosis is a condition that impacts the brain and spinal cord, leading to a wide array of potential symptoms, including challenges with vision, coordination in the arms or legs, sensation, or balance. As...Read Moreby Nicholas FeenieMarch 28, 2024 Artificial Intelligence, Digital Health, Medication, Weight Loss0 comments
Artificial intelligence discovers potential plant extracts for obesity treatment
In an innovative study utilising artificial intelligence (AI), researchers have identified two plant-based compounds with the potential to act as GLP-1 agonist weight loss medications. This significant finding will be presented at the European Congress on Obesity (ECO 2024), set to take place in Venice from 12th to 15th May, 2024. GLP-1 (Glucagon-like peptide-1) receptor agonists, such as...Read MoreDigital health and wellness tools lead to fewer GP visits in the UK
In a striking advancement for digital healthcare, Primary Care Networks (PCNs) leveraging the Holly Health digital wellness and behaviour modification platform have reported a notable decline in the demand for GP consultations. This pioneering tool aids patients in adopting and maintaining healthier behaviours in a lasting manner, which has led to fewer medical appointments being...Read Moreby Nicholas FeenieMarch 26, 2024 Artificial Intelligence, Digital Health, Telehealth, United States of America0 comments